Ticker Details
Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
IPO Date:	February 22, 2000
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$330.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.90%
Avg Daily Range (30 D):	$0.18 | 3.01%
Avg Daily Range (90 D):	$0.21 | 3.12%

Institutional Daily Volume
Avg Daily Volume:	3.6M
Avg Daily Volume (30 D):	.93M
Avg Daily Volume (90 D):	.61M

Trade Size
Avg Trade Size (Sh.):	441
Avg Trade Size (Sh.) (30 D):	124
Avg Trade Size (Sh.) (90 D):	111

Institutional Trades
Total Institutional Trades:	446
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$.78M
Avg Institutional Trade (90 D):	$.74M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.39M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$.83M
Avg Closing Volume:	82.96K

News

May 1, 2026 @ 1:50 AM Senseonics Announces Pricing of $80 Million Public... Source: Na

Apr 29, 2026 @ 8:31 AM Middle East and Africa Continuous Glucose Monitori... Source: Researchandmarkets.Com

Apr 24, 2026 @ 11:00 AM Senseonics Announces European Launch of EversenseÃ... Source: Na

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Mar 14, 2026 @ 2:15 PM First Ever Real-World Evidence of Eversense 365 Pr... Source: Senseonics Holdings, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.63	$-.71	$-.47
Diluted EPS	$-1.63	$-.71	$-.47
Revenue	$40.71M	$11.71M	$14.26M
Gross Profit	$21.2M	$6.94M	$7.67M
Net Income / Loss	$-87.19M	$-32.33M	$-20.82M
Operating Income / Loss	$-86.7M	$-31.85M	$-20.93M
Cost of Revenue	$19.51M	$4.77M	$6.59M
Net Cash Flow	$-9.7M	$-10.62M	$5.78M
PE Ratio

Splits
Oct 20, 2025	1:20
Nov 10, 2015	12:1